| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.27 | 2e-07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-06 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.28 | 7e-06 |